Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 108, Issue Suppl 1
107 Empagliflozin in heart failure with a preserved ejection fraction ≥50%: results from the emperor-preserved clinical trial
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Heart failure
107 Empagliflozin in heart failure with a preserved ejection fraction ≥50%: results from the emperor-preserved clinical trial
Free
Online download statistics by month:
Online download statistics by month: July 2022 to December 2022
Abstract
Full
Pdf
Jun 2022
118
0
27
Jul 2022
142
0
34
Aug 2022
188
0
34
Sep 2022
229
0
23
Oct 2022
214
0
29
Nov 2022
121
0
11
Dec 2022
72
0
4
Total
1084
0
162
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF